Education
About Us
Working with TipRanks
Follow Us
Nuwellis (NUWE)
NASDAQ:NUWE
Earnings Data
Report Date
May 12, 2026TBA (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
-1Last Year’s EPS
-28.98Same Quarter Last Year
Based on 1 Analysts Ratings
Earnings Call Summary
Q4 2025
Earnings Call Date:Mar 10, 2026|
% Change Since:
|
Earnings Call Sentiment|Neutral
The call conveyed a mixed picture: management highlighted operational strengthening (manufacturing transition, margin improvement, focused commercial deployment), strategic clarity (cardiorenal focus, pediatric IP and NIH funding), and pockets of strong product performance (Q4 revenue growth, 208% increase in U.S. console sales). Offsetting these positives were continued top-line pressure for the year (full-year revenue down 5%), sizable net losses ($17.5M), significant cash burn with only ~$1.2M cash on hand at year-end, declines in critical care revenue, and reliance on financings and one-time accounting charges. Overall, the transcript presents balanced progress on restructuring and margin work but material near-term financial constraints and execution risks remain.Company Guidance
Fourth Quarter Revenue Growth
Revenue for Q4 2025 was $2.4 million, up 4% year-over-year and up 9% sequentially, driven primarily by increased utilization within targeted accounts.
Sharp Increase in U.S. Console Sales and ASP
U.S. console sales increased 208% year-over-year (eight units sold vs. three in the prior-year quarter); circuit average selling price increased 11% year-over-year in the quarter.
Gross Margin Expansion
Gross margin expanded to 68.2% in Q4 2025 (versus 58.4% in prior-year quarter; +9.9 percentage points) and full-year gross margin improved to 62% (up ~3 percentage points year-over-year).
Operational and Strategic Realignment
Company completed transition of manufacturing to KDI Precision Manufacturing to improve reliability and structural margins, simplified international footprint (exiting loss-making EU territories), and refocused strategy on the cardiorenal continuum.
Pediatrics and Heart Failure Traction, NIH Support
Reported strong growth in heart failure and pediatrics (call stated 814% year-over-year growth for these areas), expanded pediatric intellectual property, and received a nondilutive NIH grant to support pediatric device development.
Acquisitions and Product Portfolio Expansion
Announced acquisition/integration activity (Rendiatek and referenced integration of RoentDeck), with plans to relaunch the Clarity product midyear and to integrate urine-output/biomarker measurement technology into ICU workflows to drive utilization.
Improved Expense Discipline and Financial Actions
Full-year operating expenses were modestly lower than prior year ($16.2 million reported), management reduced discretionary spend (terminated an expensive clinical trial), and the company raised approximately $7 million in net proceeds during 2025 while ending the year with no outstanding debt.
NUWE Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
NUWE Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Mar 10, 2026 | $1.29 | $1.30 | +0.78% |
Nov 12, 2025 | $2.78 | $2.67 | -3.96% |
Aug 14, 2025 | $5.50 | $5.64 | +2.55% |
May 13, 2025 | $41.58 | $41.96 | +0.91% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Nuwellis (NUWE) report earnings?
Nuwellis (NUWE) is schdueled to report earning on May 12, 2026, TBA (Confirmed).
What is Nuwellis (NUWE) earnings time?
Nuwellis (NUWE) earnings time is at May 12, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is NUWE EPS forecast?
NUWE EPS forecast for the fiscal quarter 2026 (Q1) is -1.